You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclin-Dependent Kinase 4 (CDK4)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +4 more
    • CDK 4/6 inhibitors
    • Endocrine therapy
    • Helsinki, Finland
    • +11 more
    Sep 19, 2023

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

    Active, not recruiting
    Has Results
    • Advanced Breast Cancer
    • Beijing, Beijing, China
    • +6 more
    Jun 23, 2022

    Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)

    Recruiting
    • Breast Cancer
    • Endocrine Therapy and a CDK 4/6 inhibitor
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 18, 2022

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

    Recruiting
    • Recurrent Endometrial Carcinoma
    • +3 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Oct 28, 2021

    Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

    Not yet recruiting
    • Preterm Labor
      • (no location specified)
      May 9, 2023

      Toxicity Data in Advanced Breast Cancer Treated With CDK

      Completed
      • Breast Cancer Stage IV
        • Athens, Greece
          Hellenic Oncology Cooperative Group
        Feb 11, 2021

        Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

        Active, not recruiting
        • Metastatic Breast Cancer
        • Breast Carcinoma
        • Birmingham, Alabama
        • +12 more
        Feb 17, 2022

        Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +2 more
        • CDK Inhibitor AT7519
        • +3 more
        • Washington, District of Columbia
        • +5 more
        Oct 18, 2022

        Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

        Recruiting
        • Chondrosarcoma
        • +2 more
        • Jacksonville, Florida
        • +3 more
        Apr 4, 2022

        Breast Cancer Trial (Chidamide+ Fulvestrant)

        Not yet recruiting
        • Breast Cancer
        • Chidamide+ Fulvestrant
        • (no location specified)
        Jan 13, 2022

        Oligodendroglioma, Oligoastrocytoma Trial in Spain (Palbociclib)

        Completed
        • Oligodendroglioma
        • Oligoastrocytoma
        • Las Palmas de Gran Canaria, Las Palmas, Spain
        • +10 more
        Apr 1, 2020

        Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

        Not yet recruiting
        • Advanced Breast Cancer
        • +6 more
        • Providence, Rhode Island
          Lifespan Cancer Institute
        Feb 1, 2023

        Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

        Completed
        Has Results
        • Breast Cancer
        • +2 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jan 13, 2022

        Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

        Not yet recruiting
        • Breast Cancer
        • +8 more
        • (no location specified)
        Feb 9, 2023

        Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

        Not yet recruiting
        • Breast Cancer
        • +5 more
        • (no location specified)
        Sep 9, 2022

        Tumors, Breast Tumors Trial in Japan (PD-0332991, letrozole)

        Completed
        Has Results
        • Neoplasms
        • Breast Neoplasms
        • Nagoya, Aichi, Japan
        • +15 more
        Oct 28, 2020

        Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

        Not yet recruiting
        • Solid Tumors
        • (no location specified)
        May 17, 2023